Compare

Tirzepatide vs Retatrutide

A dual-hormone medication available today vs an investigational triple-hormone agonist — compared by a physician.

Medically reviewed by Charles Kamen, MD, board-certified neurologist ·

Tirzepatide vs Retatrutide — abstract science illustration, LiveNow Longevity, Las Vegas

Tirzepatide and retatrutide are both injectable medications studied for weight management, but they are at very different stages. Tirzepatide is FDA-approved and available now. Retatrutide is an investigational drug still in clinical trials — it is not yet FDA-approved or commercially available.

At LiveNow Longevity we prescribe only FDA-approved options after a complete medical evaluation. This page is educational and explains how the two differ; it is not medical advice, and we do not offer investigational drugs.

TirzepatideRetatrutide
Hormone pathwaysGIP + GLP-1 (dual agonist)GIP + GLP-1 + glucagon (triple agonist)
FDA statusFDA-approved (Mounjaro, Zepbound)Investigational — not FDA-approved
AvailabilityAvailable now, when appropriateIn clinical trials; not commercially available
AdministrationOnce-weekly injectionOnce-weekly injection (in trials)
How we decidePrescribed after evaluation when appropriateNot prescribed unless and until FDA-approved

Bottom line: Tirzepatide is an FDA-approved, dual-hormone medication available today. Retatrutide adds a third hormone pathway (glucagon) and has shown promise in early trials, but it is investigational and not yet available. We work with FDA-approved options, chosen after a medical evaluation.

More on TirzepatideMore on Retatrutide

Frequently Asked Questions

Can I get retatrutide in Las Vegas?

Not yet. Retatrutide is an investigational drug still in clinical trials and is not FDA-approved or commercially available anywhere. We prescribe FDA-approved options, such as tirzepatide or semaglutide, when appropriate after evaluation.

What is the difference between tirzepatide and retatrutide?

Tirzepatide acts on two hormone pathways (GIP and GLP-1); retatrutide is designed to act on three (GIP, GLP-1, and glucagon). Tirzepatide is FDA-approved; retatrutide is still investigational.

Which is better for weight loss?

Retatrutide has shown promising results in early trials, but it is not yet available and long-term data are still being gathered. For patients today, the appropriate FDA-approved option is determined by Dr. Kamen after a medical evaluation.

How do I get started?

Book online or call (702) 808-2650 to schedule your evaluation in Las Vegas.

Physician-Led in Las Vegas

Which one is right for you?

That is a medical decision — and exactly what the $88 evaluation is for. Dr. Charles Kamen, MD reviews your labs, history, and goals and recommends the option that fits you.

Visit our clinic in Las Vegas

Ready to Start Your Longevity Journey?

Schedule a consultation with Dr. Kamen today.

Book Your Consultationphysician-led peptide therapy Las Vegas — visit our clinic